10x Genomics (TXG) Price & Analysis

Compare

1,213 Followers

TXG Stock Chart & Stats

$17.47

-$0.12(-0.77%)

At close: Jan 08 4:00 PM EST

$17.47

-$0.12(-0.77%)

Day’s Range― - ―

52-Week Range$6.78 - $20.34

Previous CloseN/A

Volume385.49K

Average Volume (3M)2.91M

Market Cap

$2.25B

Enterprise Value$1.07B

Total Cash (Recent Filing)$482.08M

Total Debt (Recent Filing)$86.98M

Price to Earnings (P/E)―

Beta1.44

Next Earnings

Feb 18, 2026

EPS Estimate

-0.22

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.22

Shares Outstanding116,474,180

10 Day Avg. Volume2,489,769

30 Day Avg. Volume2,906,280

Financial Highlights & Ratios

PEG Ratio0.31

Price to Book (P/B)2.44

Price to Sales (P/S)2.83

P/FCF Ratio-301.92

Enterprise Value/Market Cap0.48

Enterprise Value/Revenue1.67

Enterprise Value/Gross Profit2.43

Enterprise Value/Ebitda-34.80

Forecast

1Y Price Target

$16.67

Price Target Upside-4.58% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering11

EPS Forecast (FY)-0.52

Revenue Forecast (FY)$633.03M

Bulls Say, Bears Say

Bulls Say

Market Position10x Genomics has the best offering in single cell with the largest install base and a technological lead vs. competitors.

Product InnovationDespite macro headwinds, TXG remains focused on execution, highlighted by the launch of new products like next-gen Chromium Flex and Xenium Protein.

Revenue PerformanceTotal revenue for 3Q25 exceeded estimates and consensus, with particular strength in Chromium revenue.

Bears Say

Demand WeaknessThere is a concern that US A&G weakness can persist while competitive risks have increased.

Market EnvironmentOngoing macro uncertainty continues to disrupt customer purchasing patterns and reduces visibility regarding the company's outlook.

Revenue DeclineRevenue was down 4% year-over-year and year-to-date.

10x Genomics News

Teradyne upgraded, Circle Internet initiated: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

8d ago

ALB

10x Genomics assumed at Equal Weight from Overweight at Morgan Stanley

Morgan Stanley analyst Kallum Titchmarsh downgraded 10x Genomics (TXG) to Equal Weight from Overweight with a price target...

9d ago

TXG

10x Genomics downgraded to Equal Weight from Overweight at Morgan Stanley

Morgan Stanley downgraded 10x Genomics (TXG) to Equal Weight from Overweight with a price target of $20, up...

9d ago

TXG

10x Genomics price target raised to $19 from $15 at Piper Sandler

Piper Sandler raised the firm’s price target on 10x Genomics (TXG) to $19 from $15 and keeps a...

30d ago

TXG

10x Genomics Announces Chief Legal Officer Retirement

10x Genomics ( ($TXG) ) has provided an update. On November 12, 2025, Eric S. Whitaker announced his...

27d ago

TXG

10X Genomics Earnings Call: Mixed Results Amid Challenges

10X Genomics (($TXG)) has held its Q3 earnings call. Read on for the main highlights of the call....

1M ago

TXG

Cathie Wood Buys the Dip in Archer Aviation (ACHR) After Weak Q3 Results, Trims Stakes in Roku and TER Stocks

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, November 6, according to daily fund...

1M ago

TER

TXG

10x Genomics: Balancing Growth Potential with Macroeconomic Challenges – Hold Rating Maintained

William Blair analyst Matt Larew has maintained their neutral stance on TXG stock, giving a Hold rating today....

1M ago

TXG

10x Genomics price target raised to $14 from $13 at UBS

UBS raised the firm’s price target on 10x Genomics (TXG) to $14 from $13 and keeps a Neutral...

1M ago

TXG

10x Genomics price target raised to $15 from $13 at JPMorgan

JPMorgan raised the firm’s price target on 10x Genomics (TXG) to $15 from $13 and keeps a Neutral...

1M ago

TXG

10x Genomics price target raised to $19 from $16 at Canaccord

Canaccord raised the firm’s price target on 10x Genomics (TXG) to $19 from $16 and keeps a Buy...

1M ago

TXG

10x Genomics price target raised to $17 from $15 at Barclays

Barclays analyst Luke Sergott raised the firm’s price target on 10x Genomics (TXG) to $17 from $15 and...

1M ago

TXG

10x Genomics: Hold Rating Amid Resilience and Challenges in U.S. Academic and Government Sectors

Daniel Brennan, an analyst from TD Cowen, maintained the Hold rating on 10x Genomics. The associated price target...

1M ago

TXG

10x Genomics Reports Q3 2025 Financial Results

10X Genomics ( ($TXG) ) has released its Q3 earnings. Here is a breakdown of the information 10X...

1M ago

TXG

TXG FAQ

What was 10X Genomics’s price range in the past 12 months?

10X Genomics lowest stock price was $6.78 and its highest was $20.34 in the past 12 months.

What is 10X Genomics’s market cap?

10X Genomics’s market cap is $2.25B.

When is 10X Genomics’s upcoming earnings report date?

10X Genomics’s upcoming earnings report date is Feb 18, 2026 which is in 69 days.

How were 10X Genomics’s earnings last quarter?

10X Genomics released its earnings results on Nov 06, 2025. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.288 by $0.068.

Is 10X Genomics overvalued?

According to Wall Street analysts 10X Genomics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does 10X Genomics pay dividends?

10X Genomics does not currently pay dividends.

What is 10X Genomics’s EPS estimate?

10X Genomics’s EPS estimate is -0.22.

How many shares outstanding does 10X Genomics have?

10X Genomics has 116,474,180 shares outstanding.

What happened to 10X Genomics’s price movement after its last earnings report?

10X Genomics reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.288. Following the earnings report the stock price went up 17.308%.

Which hedge fund is a major shareholder of 10X Genomics?

Currently, no hedge funds are holding shares in TXG

10x Genomics Stock Smart Score

Underperform

Fundamentals

Return on Equity

-10.12%

Trailing 12-Months

Asset Growth

9.55%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

10X Genomics

10x Genomics (TXG) is a biotechnology company that specializes in genomic sequencing and analysis technologies. Founded in 2012 and headquartered in Pleasanton, California, the company operates primarily in the life sciences sector, providing advanced solutions for single-cell analysis, spatial genomics, and immune profiling. 10x Genomics' core products include their Chromium platform and associated reagents, which enable researchers to conduct high-throughput genomic studies across various applications, including cancer research, immunology, and drug discovery.

10x Genomics (TXG) Earnings & Revenues

Historic Earnings Reports

TXG Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call presented a mixed picture, with strong performance in spatial consumables and successful new product launches offset by declines in overall revenue and instrument sales. Ongoing macroeconomic challenges and funding uncertainties continue to pose challenges.View all TXG earnings summaries

TXG Revenue Breakdown

60.32% Americas

22.99% EMEA

8.45% Asia-Pacific excluding China

8.24% China

TXG Stock 12 Month Forecast

Average Price Target

$16.67

▼(-4.58% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","14":"$14","21":"$21","10.5":"$10.5","17.5":"$17.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,10.5,14,17.5,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.08,18.227692307692305,18.375384615384615,18.52307692307692,18.67076923076923,18.818461538461538,18.966153846153844,19.113846153846154,19.26153846153846,19.409230769230767,19.556923076923077,19.704615384615384,19.852307692307694,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.08,17.97153846153846,17.86307692307692,17.754615384615384,17.646153846153844,17.537692307692307,17.42923076923077,17.32076923076923,17.212307692307693,17.103846153846156,16.995384615384616,16.88692307692308,16.77846153846154,{"y":16.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.08,17.766153846153845,17.45230769230769,17.138461538461538,16.824615384615385,16.51076923076923,16.196923076923078,15.883076923076922,15.569230769230769,15.255384615384614,14.94153846153846,14.627692307692307,14.313846153846153,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.47,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.36,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.69,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.67,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.06,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.08,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.37,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.39,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.64,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.08,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >